Previous 10 | Next 10 |
Actions bring sharpened focus on MCM and NARCAN ® Nasal Spray products Expected to improve operational efficiencies and deliver annual cost savings over $100 million annually GAITHERSBURG, Md., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) today announced ...
2023-08-01 08:26:13 ET Stock futures dipped early Tuesday as the corporate earnings season kicks into high gear. Here are some of Tuesday's biggest stock movers in premarket trading: Biggest stock gainers For further details see: Biggest stock movers today: Arista Netwo...
GAITHERSBURG, Md., July 31, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that it was awarded a 10-year contract by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) withi...
GAITHERSBURG, Md., July 25, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 8, 2023, at 5:00 pm eastern time to discuss the financial results for the second quarter of 2023, recent business developments, revenue guidance for the third...
2023-07-21 08:14:47 ET BioNexus Gene Lab Corp ( BGLC ) +56% . Digital World Acquisition ( DWAC ) +23% jumps 29% amid settlement with SEC. Guardforce AI ( GFAI ) +16% . Bragg Gaming Group ( BRAG ) +13% . Emergent BioSolu...
2023-07-21 05:52:56 ET U.S. stock futures inched higher during Friday's early hours of trade after the Dow celebrated its longest rise since 2017, with a ninth day of gains. Nasdaq futures are also recovering after their worst session since early March . Here are some of Friday's bi...
2023-07-21 05:42:00 ET Summary Today, we take a look at a life sciences company called Emergent BioSolutions. The company is making a big bet on the NARCAN marketplace, selling one business and getting FDA approval for a new OTC product. An investment analysis around Emergent ...
Emergent has been delivering CYFENDUS™ vaccine to the U.S. Department of Health and Human Services since 2019, under pre-Emergency Use Authorization status, and will continue to work with the U.S. government to transition to post-approval procurement GAITHERSBURG, Md., July 20, 202...
2023-06-27 17:30:25 ET Contract healthcare manufacturing company Emergent BioSolutions (NYSE: EBS) was looking a bit under the weather as far as its stock was concerned on Tuesday. The company's share price plummeted by nearly 9% on the day following the news of a top-level executiv...
2023-06-27 13:38:04 ET Emergent BioSolutions ( NYSE: EBS ) said Tuesday that president and chief executive officer Robert G. Kramer Sr. will retire and step down from his positions effective immediately. The company has named Haywood Miller as interim...
News, Short Squeeze, Breakout and More Instantly...
Emergent Biosolutions Inc. Company Name:
EBS Stock Symbol:
NYSE Market:
Emergent Biosolutions Inc. Website:
New video and radio segments raise awareness of a potentially life-saving, three-step method that anyone can use to respond in a suspected opioid poisoning GAITHERSBURG, Md., July 24, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced the launch of a new opio...
GAITHERSBURG, Md., July 23, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Tuesday, August 6, 2024, at 5:00 pm eastern time to discuss the financial results for the second quarter 2024, key business updates, revenue guidance for the third quarter of...
The extension to a four-year shelf-life helps improve naloxone access as communities continue to grapple with the growing opioid epidemic; product with the extended shelf life has officially begun shipping WINNIPEG, Manitoba, July 22, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolution...